Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

The future of uveitis treatment.

Lin P, Suhler EB, Rosenbaum JT.

Ophthalmology. 2014 Jan;121(1):365-76. doi: 10.1016/j.ophtha.2013.08.029. Epub 2013 Oct 26. Review.

PMID:
24169255
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Non-infectious pediatric uveitis: an update on immunomodulatory management.

Sharma SM, Dick AD, Ramanan AV.

Paediatr Drugs. 2009;11(4):229-41. doi: 10.2165/00148581-200911040-00002. Review.

PMID:
19566107
[PubMed - indexed for MEDLINE]
3.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
[PubMed - indexed for MEDLINE]
4.

Therapeutic targeting of STAT3 (signal transducers and activators of transcription 3) pathway inhibits experimental autoimmune uveitis.

Yu CR, Lee YS, Mahdi RM, Surendran N, Egwuagu CE.

PLoS One. 2012;7(1):e29742. doi: 10.1371/journal.pone.0029742. Epub 2012 Jan 5.

PMID:
22238646
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Emerging drugs for uveitis.

Larson T, Nussenblatt RB, Sen HN.

Expert Opin Emerg Drugs. 2011 Jun;16(2):309-22. doi: 10.1517/14728214.2011.537824. Epub 2011 Jan 6. Review.

PMID:
21210752
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Cytokines in immunotherapy of experimental uveitis.

de Kozak Y, Verwaerde C.

Int Rev Immunol. 2002 Mar-Jun;21(2-3):231-53. Review.

PMID:
12424845
[PubMed - indexed for MEDLINE]
7.

Immunotherapeutic approaches in ocular inflammatory diseases.

Kurup SK, Chan CC.

Arch Immunol Ther Exp (Warsz). 2005 Nov-Dec;53(6):484-96. Review.

PMID:
16407781
[PubMed - indexed for MEDLINE]
8.

Anti-inflammatory therapy in uveitis.

Majumder PD, Sudharshan S, Biswas J.

Recent Pat Inflamm Allergy Drug Discov. 2009 Nov;3(3):188-94. Review.

PMID:
19607645
[PubMed - indexed for MEDLINE]
9.

Emerging drugs for asthma.

Walsh GM.

Expert Opin Emerg Drugs. 2008 Dec;13(4):643-53. doi: 10.1517/14728210802591378 . Review. Erratum in: Expert Opin Emerg Drugs. 2009 Mar;14(1):205.

PMID:
19046132
[PubMed - indexed for MEDLINE]
10.

New treatment options for noninfectious uveitis.

Gomes Bittencourt M, Sepah YJ, Do DV, Agbedia O, Akhtar A, Liu H, Akhlaq A, Annam R, Ibrahim M, Nguyen QD.

Dev Ophthalmol. 2012;51:134-61. doi: 10.1159/000336338. Epub 2012 Apr 17. Review.

PMID:
22517211
[PubMed - indexed for MEDLINE]
11.

Emerging biologics in the treatment of uveitis.

Yeh S, Nussenblatt RB, Levy-Clarke GA.

Expert Rev Clin Immunol. 2007 Sep;3(5):781-96. doi: 10.1586/1744666X.3.5.781.

PMID:
20477028
[PubMed]
12.

Uveitis, the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT), and intravitreal biologics for ocular inflammation.

Yeh S, Albini TA, Moshfeghi AA, Nussenblatt RB.

Am J Ophthalmol. 2012 Sep;154(3):429-435.e2. doi: 10.1016/j.ajo.2012.05.011. Review.

PMID:
22898344
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Immunomodulatory therapy for ocular inflammatory disease: a basic manual and review of the literature.

Okada AA.

Ocul Immunol Inflamm. 2005 Sep-Oct;13(5):335-51. Review.

PMID:
16419419
[PubMed - indexed for MEDLINE]
14.

Systematic review of anti-tumor necrosis factor-alpha therapy for treatment of immune-mediated uveitis.

Cordero-Coma M, Yilmaz T, Onal S.

Ocul Immunol Inflamm. 2013;21(1):19-27. doi: 10.3109/09273948.2012.723107. Review.

PMID:
23323577
[PubMed - indexed for MEDLINE]
15.

Immunotherapeutic strategies in autoimmune uveitis.

Papotto PH, Marengo EB, Sardinha LR, Goldberg AC, Rizzo LV.

Autoimmun Rev. 2014 May 12. pii: S1568-9972(14)00122-0. doi: 10.1016/j.autrev.2014.05.003. [Epub ahead of print] Review.

PMID:
24833504
[PubMed - as supplied by publisher]
Free Article
16.

[Therapeutics for future treatment of uveitis].

Deschênes J.

Bull Soc Belge Ophtalmol. 2000;276:7-11. French.

PMID:
10925522
[PubMed - indexed for MEDLINE]
17.

Update on emerging drug therapies for systemic lupus erythematosus.

Mok CC.

Expert Opin Emerg Drugs. 2010 Mar;15(1):53-70. doi: 10.1517/14728210903535878. Review.

PMID:
20148712
[PubMed - indexed for MEDLINE]
18.

[Options and strategy for the treatment of chronic endogenous uveitis].

Garweg JG.

Klin Monbl Augenheilkd. 2007 Apr;224(4):367-72. Review. German.

PMID:
17458817
[PubMed - indexed for MEDLINE]
19.

Mechanisms of TNFα regulation in uveitis: focus on RNA-binding proteins.

Khera TK, Dick AD, Nicholson LB.

Prog Retin Eye Res. 2010 Nov;29(6):610-21. doi: 10.1016/j.preteyeres.2010.08.003. Epub 2010 Sep 8. Review. Erratum in: Prog Retin Eye Res. 2011 Mar;30(2):147.

PMID:
20813201
[PubMed - indexed for MEDLINE]
20.

New biologic drugs: anti-interleukin therapy.

Tappeiner C, Möller B, Hennig M, Heiligenhaus A.

Dev Ophthalmol. 2012;51:79-89. doi: 10.1159/000336190. Epub 2012 Apr 17. Review.

PMID:
22517206
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk